Skip to main content

Table 3 Spirometry and DLCO in symptomatic and non-symptomatic patients

From: Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study

 

No Dyspnea (n = 18)

Dyspnea (n = 15)

Overall population (n = 33)

P value

FEV1 (liters)

2.9 ± 0.75

3 ± 0.8

3 ± 0.76

0.96

FEV1 (%)

100 ± 19.5

99.8 ± 19.7

100 ± 19

0.95

FVC (liters)

3.6 ± 0.93

3.6 ± 1.09

3.6 ± 0.9

0.99

FVC (%)

97 ± 17

98 ± 20

97 ± 18.6

0.95

FEV1/FVC (%)

103 ± 11.2

106.3 ± 6.3

105 ± 9.2

0.39

DLCO (mL/mmHg/min)

78.4 ± 16.7

83 ± 15.7

81 ± 16

0.41

DLCO/VA (mL/mmHg/min/L)

98.5 ± 16

104.9 ± 17

101 ± 16.4

0.27

  1. FEV1 Forced Expiratory Volume in the 1st second, FVC forced vital capacity, DLCO diffusing capacity for carbon monoxide, VA alveolar volume